Valion Bio, Inc. (VBIO) Gross margin 2021–2024
Valion Bio, Inc. (VBIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
0.3%FY2024 · since FY2021: -3.0% → 0.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 0.3% | -24.1 pp |
| FY2023 | 24.4% | +8.2 pp |
| FY2022 | 16.3% | +19.3 pp |
| FY2021 | -3.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →